Schering-Plough Animal Health Corporation, Worldwide Aquaculture, is a world leader in the development of vaccines and antibiotics for the treatment and control of diseases in farmed fish and other aquatic species in the global aquaculture industry.

Headquartered in Kenilworth, N.J., Schering-Plough Corporation is a research-based company engaged in the discovery, development, manufacturing and marketing of pharmaceutical products worldwide.

Schering-Plough Aquaculture offers fully-integrated disease management solutions for the treatment and control of diseases in farmed fish and other aquatic species. Its commitment to providing cost-effective, environmentally friendly aquaculture solutions throughout the production cycle is exemplified through innovative research and development, quality products, technical services and global industry support.

Schering-Plough Aquaculture offers a diverse selection of effective aquaculture pharmaceuticals such as SLICE* and Aquaflor* to control and manage important aquatic pathogens. In addition, a unique Total Protection Strategy approach to maintaining fish health is also offered through a wide range of patented AquaVac* monovalent and combination vaccines for the prevention of many fish diseases infecting cultured species. Schering-Plough Aquaculture exclusively offers vaccines for oral administration to fish as well as injection and immersion.

The Total Protection Strategies approach to disease prevention, provides on farm flexibility and optimum protection, while minimizing stress, handling of fish and overall disruption within the fish farming operation. Schering-Plough Aquaculture technical experts are also available to build customized vaccination and treatment programs to meet your specific needs.